Dr. Laszlo Mechtler is the Chief Medical Officer at the DENT Neurologic Institute, the largest outpatient neuroscience center in the United States. Dr. Mechtler is the Director of the DENT Cannabis Clinic, which has more than 15,000 patients certified through the NYS MMJ program and continues to grow each day. 

He has published some of the first major retrospective research trials on Medical Marijuana in Headaches and other neurologic disorders and lectures both nationally and internationally and is recognized as a leader in the fields of Neuroimaging, Headache Medicine, Neuro-Oncology, and Medical Cannabis. Dr. Mechtler is also a member for he CannMed 24 Advisory Board. 

During our conversation we discuss: 

• How the DENT Institute is uniquely positioned to study medical cannabis for a variety of conditions 
  
• Results from recent studies conducted at the DENT Cannabis Clinic
  
• The challenges of studying cannabis medicine and how a proposed rescheduling could help 
  
• The ongoing struggle to convince fellow clinicians and medical associations that medical cannabis is legitimate 
  

Thanks to This Episode’s Sponsor: The DENT Institute

With more than 300,000 patient visits per year, the DENT Neurologic Institute ranks among the largest neuroscience centers in North America. Its 24 subspecialty clinics often treat the most challenging neurologic conditions including but not limited to Migraine, Chronic pain, ALS, MS, Parkinson’s, Dementia, and Neuro-Oncology. With their mission of advancing neuroscience, the Dent Institute established a cannabis clinic in 2016 to aid in the treatment of these chronic conditions seen throughout the institute.

Learn more at dentinstitute.com

Additional Resources

• Register for CannMed 24
  
• Submit an Abstract for CannMed 24
  
• Review the Podcast!
  
• CannMed Archive
  
• CannMed Community Board [Facebook Group]